Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K0706 (Vodobatinib) in Dementia With Lewy Bodies (DLB)
NCT03996460Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Sep 2019
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vodobatinib in dementia with Lewy bodies (DLB), sponsored by Georgetown University. Started Sep 2019; status: terminated.
02
Drugs
vodobatinib
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT03996460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996460.